Xiao Dong

Dr. Xiao Dong


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CSCarolina Soto-Palma
Carolina Soto-Palma
LNLaura J. Niedernhofer
Laura J. Niedernhofer
CFChristopher D. Faulk
Christopher D. Faulk
XDXiao Dong
Xiao Dong
Over the course of a human lifespan, genome integrity erodes, leading to an increased abundance of several types of chromatin changes. The abundance of DNA lesions (chemical perturbations to nucleotides) increases with age, as does the number of genomic mutations and transcriptional disruptions caused by replication or transcription of those lesions, respectively. At the epigenetic level, precise DNA methylation patterns degrade, likely causing increasingly stochastic variations in gene expression. Similarly, the tight regulation of histone modifications begins to unravel. The genomic instability caused by these mechanisms allows transposon element reactivation and remobilization, further mutations, gene dysregulation, and cytoplasmic chromatin fragments. This cumulative genomic instability promotes cell signaling events that drive cell fate decisions and extracellular communications known to disrupt tissue homeostasis and regeneration. In this Review, we focus on age-related epigenetic changes and their interactions with age-related genomic changes that instigate these events.

11 April 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ZHZhenqiu Huang
Zhenqiu Huang
SSShixiang Sun
Shixiang Sun
MLMoonsook Lee
Moonsook Lee
AMAlexander Y. Maslov
Alexander Y. Maslov
MSMiao Shi
Miao Shi
JVJan Vijg
Jan Vijg

21 September 2022 in Frontiers in Aging
Verified
Journal Article
Open access
PRPeijun Ren
Peijun Ren
XDXiao Dong
Xiao Dong
JVJan Vijg
Jan Vijg
The genome of multicellular organisms carries the hereditary information necessary for the development of all organs and tissues and to maintain function in adulthood. To ensure the genetic stability of the species, genomes are protected against changes in sequence information. However, genomes are not static. De novo mutations in germline cells are passed on to offspring and generate the variation needed in evolution. Moreover, postzygotic mutations occur in all somatic cells during development and aging. These somatic mutations remain limited to the individual, generating tissues that are genome mosaics. Insight into such mutations and their consequences has been limited due to their extremely low abundance, with most mutations unique for each cell. Recent advances in sequencing, including whole genome sequencing at the single-cell level, have now led to the first insights into somatic mutation burdens in human tissues. Here, we will first briefly describe the latest methodology for somatic mutation analysis, then review our current knowledge of somatic mutation burden in human tissues and, finally, briefly discuss the possible functional impact of somatic mutations on the aging process and age-related diseases, including cancer and diseases other than cancer.

8 April 2022 in Science Advances
Verified
Journal Article
Open access
AMAlexander Y. Maslov
Alexander Y. Maslov
SMSergey Makhortov
Sergey Makhortov
SSShixiang Sun
Shixiang Sun
JHJohanna Heid
Johanna Heid
XDXiao Dong
Xiao Dong
JVJan Vijg
Jan Vijg
Postzygotic somatic mutations have been found associated with human disease, including diseases other than cancer. Most information on somatic mutations has come from studying clonally amplified mutant cells, based on a growth advantage or genetic drift. However, almost all somatic mutations are unique for each cell, and the quantitative analysis of these low-abundance mutations in normal tissues remains a major challenge in biology. Here, we introduce single-molecule mutation sequencing (SMM-seq), a novel approach for quantitative identification of point mutations in normal cells and tissues.

11 October 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SSShixiang Sun
Shixiang Sun
YWYujue Wang
Yujue Wang
AMAlexander Y. Maslov
Alexander Y. Maslov
XDXiao Dong
Xiao Dong
JVJan Vijg
Jan Vijg
De novo mutations, a consequence of errors in DNA repair or replication, have been reported to accumulate with age in normal tissues of humans and model organisms. This accumulation during development and aging has been implicated as a causal factor in aging and age-related pathology, including but not limited to cancer. Due to their generally very low abundance mutations have been difficult to detect in normal tissues. Only with recent advances in DNA sequencing of single-cells, clonal lineages or ultra-high-depth sequencing of small tissue biopsies, somatic mutation frequencies and spectra have been unveiled in several tissue types. The rapid accumulation of such data prompted us to develop a platform called SomaMutDB (https://vijglab.einsteinmed.org/SomaMutDB) to catalog the 2.42 million single nucleotide variations (SNVs) and 0.12 million small insertions and deletions (INDELs) thus far identified using these advanced methods in nineteen human tissues or cell types as a function of age or environmental stress conditions. SomaMutDB employs a user-friendly interface to display and query somatic mutations with their functional annotations. Moreover, the database provides six powerful tools for analyzing mutational signatures associated with the data. We believe such an integrated resource will prove valuable for understanding somatic mutations and their possible role in human aging and age-related diseases.

29 October 2021 in Science Advances
Verified
Journal Article
Open access
LZLei Zhang
Lei Zhang
XDXiao Dong
Xiao Dong
XTXiao Tian
Xiao Tian
MLMoonsook Lee
Moonsook Lee
JAJulia Ablaeva
Julia Ablaeva
JVJan Vijg
Jan Vijg
Somatic mutation rates are inversely correlated with life span in mouse, guinea pig, blind mole-rat, naked mole-rat, and humans.